BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26492310)

  • 1. Left atrial appendage occlusion in atrial fibrillation for stroke prevention: A systemic review.
    Zhou X; Zhang W; Lv W; Zhou Q; Li Y; Zhang L; Lu Y; Zhang J; Xing Q; Wang H; Tang B
    Int J Cardiol; 2016 Jan; 203():55-9. PubMed ID: 26492310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-Level Analysis of Watchman Left Atrial Appendage Occlusion in Practice Versus Clinical Trials.
    Friedman DJ; Du C; Wang Y; Agarwal V; Varosy PD; Masoudi FA; Holmes DR; Reddy VY; Price MJ; Curtis JP; Freeman JV
    JACC Cardiovasc Interv; 2022 May; 15(9):950-961. PubMed ID: 35512918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.
    Holmes DR; Kar S; Price MJ; Whisenant B; Sievert H; Doshi SK; Huber K; Reddy VY
    J Am Coll Cardiol; 2014 Jul; 64(1):1-12. PubMed ID: 24998121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial.
    Reddy VY; Doshi SK; Sievert H; Buchbinder M; Neuzil P; Huber K; Halperin JL; Holmes D;
    Circulation; 2013 Feb; 127(6):720-9. PubMed ID: 23325525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial.
    Korsholm K; Damgaard D; Valentin JB; Packer EJS; Odenstedt J; Sinisalo J; Putaala J; Næss H; Al-Jazi MA; Karlsson JE; Pontoppidan J; Modrau B; Hjort J; Matzen KL; Johnsen SP; Nielsen-Kudsk JE
    Am Heart J; 2022 Jan; 243():28-38. PubMed ID: 34537184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over 1-year efficacy and safety of left atrial appendage occlusion versus novel oral anticoagulants for stroke prevention in atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials and observational studies.
    Li X; Wen SN; Li SN; Bai R; Liu N; Feng L; Ruan YF; Du X; Dong JZ; Ma CS
    Heart Rhythm; 2016 Jun; 13(6):1203-14. PubMed ID: 26724488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation.
    Alli O; Doshi S; Kar S; Reddy V; Sievert H; Mullin C; Swarup V; Whisenant B; Holmes D
    J Am Coll Cardiol; 2013 Apr; 61(17):1790-8. PubMed ID: 23500276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.
    Viles-Gonzalez JF; Kar S; Douglas P; Dukkipati S; Feldman T; Horton R; Holmes D; Reddy VY
    J Am Coll Cardiol; 2012 Mar; 59(10):923-9. PubMed ID: 22381428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5-Year, Long-Term Data.
    Reddy VY; Akehurst RL; Gavaghan MB; Amorosi SL; Holmes DR
    J Am Heart Assoc; 2019 Jul; 8(13):e011577. PubMed ID: 31230500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fibrillation: a meta-analysis.
    Tsai YC; Phan K; Munkholm-Larsen S; Tian DH; La Meir M; Yan TD
    Eur J Cardiothorac Surg; 2015 May; 47(5):847-54. PubMed ID: 25064051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Atrial Appendage Occlusion: A Narrative Review.
    Alsagheir A; Koziarz A; Belley-Côté EP; Whitlock RP
    J Cardiothorac Vasc Anesth; 2019 Jun; 33(6):1753-1765. PubMed ID: 30857852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, Characteristics, and Clinical Course of Device-Related Thrombus After Watchman Left Atrial Appendage Occlusion Device Implantation in Atrial Fibrillation Patients.
    Kubo S; Mizutani Y; Meemook K; Nakajima Y; Hussaini A; Kar S
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1380-1386. PubMed ID: 29759668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left atrial appendage occlusion in recurrent ischaemic stroke, a multicentre experience.
    Galloo X; Carmeliet T; Prihadi EA; Lochy S; Scott B; Verheye S; Schoors D; Vermeersch P
    Acta Clin Belg; 2022 Apr; 77(2):255-260. PubMed ID: 32951514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex Differences in the Clinical Outcomes After Left Atrial Appendage Closure: A Systematic Review and Meta-Analysis.
    Abusnina W; Latif A; Al-Abdouh A; Mostafa MR; Radaideh Q; Alshebani Y; Aboeata A; Ben-Dor I; Michos ED; Dahal K
    Cardiovasc Revasc Med; 2022 Aug; 41():29-34. PubMed ID: 34952822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations for Left Atrial Appendage Occlusion During Cardiac Surgery.
    Sylvester CB; Patel V; Ghanta RK; Loor G
    Cardiovasc Drugs Ther; 2023 Oct; 37(5):1011-1019. PubMed ID: 36550349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.
    Grosset-Janin D; Barth E; Bertrand B; Detante O
    Rev Neurol (Paris); 2015 May; 171(5):426-32. PubMed ID: 25912470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials.
    Hanif H; Belley-Cote EP; Alotaibi A; Dvirnik N; Neupane B; Beyene J; Eikelboom JW; Holmes D; Whitlock RP
    J Cardiovasc Surg (Torino); 2018 Feb; 59(1):128-139. PubMed ID: 28215062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis.
    Holmes DR; Doshi SK; Kar S; Price MJ; Sanchez JM; Sievert H; Valderrabano M; Reddy VY
    J Am Coll Cardiol; 2015 Jun; 65(24):2614-2623. PubMed ID: 26088300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation : A Decision Analysis.
    Chew DS; Zhou K; Pokorney SD; Matchar DB; Vemulapalli S; Allen LA; Jackson KP; Samad Z; Patel MR; Freeman JV; Piccini JP
    Ann Intern Med; 2022 Sep; 175(9):1230-1239. PubMed ID: 35969865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.